Clinical Trial Update: Clinical Study of CD7 CAR-T Cells for Relapsed/refractory Autoimmune Diseases [NA]

View source ↗

Summary

A clinical trial is planned to evaluate CD7 CAR-T cells for relapsed/refractory autoimmune diseases, specifically systemic sclerosis, with recruitment not yet s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• CD7 CAR-T cells (CD7 CAR-T cells)

Snippet

Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd. | Conditions: Systemic Sclerosis - 2013 ACR/EULAR Classification Criteria | NA | Status: NOT_YET_RECRUITING